Congenital Hematological Disorder Completed Phase 1 Trials for Turoctocog alfa (DB09109)

Back to Congenital Hematological Disorder

Also known as: Congenital bleeding disorders / Congenital Bleeding Disorder / Congenital haematological disorder

IndicationStatusPhase
DBCOND0081791 (Congenital Hematological Disorder)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02941354Evaluating the Pharmacokinetics of NovoEight® (Turoctocog Alfa) in Relation to BMI in Subjects With Haemophilia ATreatment
NCT01692925Investigation of the Pharmacokinetics of Turoctocog Alfa in Subjects With Haemophilia ATreatment
NCT01365520A Single Dose Trial of NNC 0155-0000-0004 in Patients With Haemophilia ATreatment
NCT01238367A Single Dose Trial of Recombinant Factor VIII (N8) in Japanese Subjects With Haemophilia A: An Extension to Trial NN7008-3543Treatment
NCT00837356Comparison of the Action of Drugs in the Body and Safety of N8 and Advate® in Haemophilia A SubjectsTreatment